Financial Summary (All financials)
| In millions, except per share items | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 |
| Revenues | 116.2 | 105.0 | 96.6 | 81.5 |
| Revenue growth | 10.6% | 8.7% | 18.5% | |
| Cost of goods sold | 56.3 | 52.0 | 50.5 | 43.8 |
| Gross profit | 59.9 | 53.0 | 46.1 | 37.7 |
| Gross margin | 51.5% | 50.5% | 47.7% | 46.2% |
| Selling, general and administrative | 41.9 | 37.8 | 33.9 | 28.4 |
| Research and development | 1.8 | 1.6 | 1.6 | 1.5 |
| EBIT | 16.9 | 13.6 | 10.6 | 5.0 |
| EBIT margin | 14.5% | 12.9% | 10.9% | 6.2% |
| Pre-tax income | 17.1 | 13.6 | 10.2 | 5.3 |
| Income taxes | 6.8 | 5.4 | 3.9 | 2.1 |
| Tax rate | 40.0% | 40.0% | 38.2% | 40.0% |
| Net income | 10.3 | 8.1 | 6.3 | 3.2 |
| Net margin | 8.8% | 7.7% | 6.5% | 3.9% |
| |
| Diluted EPS | $0.76 | $0.60 | $0.49 | $0.51 |
| Shares outstanding (diluted) | 13.5 | 13.5 | 13.0 | 6.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|